Related references
Note: Only part of the references are listed.Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer
Zhiyu Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles
Ruifeng Wu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine
Yuan Hong et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides
Gang Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy
Jing Xing et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
The antitoxic effects of quercetin and quercetin-conjugated iron oxide nanoparticles (QNPs) against H2O2-induced toxicity in PC12 cells
Zahra Yarjanli et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer
Jing Zhang et al.
ACS NANO (2019)
Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats
Jalil Rashedi et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin
Sheng Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
A highly GSH-sensitive SN-38 prodrug with an OFF-to-ON fluorescence switch as a bifunctional anticancer agent
Chang-Hee Whang et al.
CHEMICAL COMMUNICATIONS (2018)
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
Jicai Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
Wendu Duan et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
Chunhui Ruan et al.
ACTA PHARMACEUTICA SINICA B (2018)
Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers
Zhiyu Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery
Kang Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer
Bo Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Drug release studies from lipid nanoparticles in physiological media by a new DSC method
Elin Roese et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
Rongrong Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer
Fengqiao Li et al.
BIOMATERIALS (2017)
Combination lung cancer chemotherapy: Design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin
Shuang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy
Baomin Zhu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma
Mingqing Yuan et al.
DRUG DELIVERY (2016)
TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA
Shufang Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats
Shouwen Zhang et al.
DRUG DELIVERY (2016)
Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system
Wenjun Chen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2016)
Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors
Tao Fang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer
Li Lv et al.
ONCOTARGET (2016)
Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer
Ilkoo Noh et al.
BIOMATERIALS (2015)
Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA
Zhenyu Shao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Magnetoelectric 'spin' on stimulating the brain
Rakesh Guduru et al.
NANOMEDICINE (2015)
Synthesis of a reactive oxygen species responsive heterobifunctional thioketal linker
Xiaoxi Ling et al.
TETRAHEDRON LETTERS (2015)
Nanoparticles containing insoluble drug for cancer therapy
Shutao Guo et al.
BIOTECHNOLOGY ADVANCES (2014)
Tumor Redox Heterogeneity-Responsive Prodrug Nanocapsules for Cancer Chemotherapy
Jinqiang Wang et al.
ADVANCED MATERIALS (2013)
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
J. P. Tiernan et al.
BRITISH JOURNAL OF CANCER (2013)
Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform
Bivash Mandal et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
A Decade of Advances in Cytotoxic Chemotherapy for Metastatic Colorectal Cancer
Amy S. Lucas et al.
CLINICAL COLORECTAL CANCER (2011)
Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
Prashant Bavi et al.
MOLECULAR CANCER (2010)
Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer
Gianluca Masi et al.
CLINICAL COLORECTAL CANCER (2008)
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest
Alfredo Falcone et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2006)
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study
SR Alberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
